Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Inc.

Humacyte ($HUMA) announced an update on their ongoing clinical study. Humacyte, Inc. is launching a Phase 4 multicenter study called “A Phase 4 Obs...

Humacyte’s Symvess Trauma Study: Real-World Data Push With Investor Upside

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Annexon Biosciences (ANNX), Humacyte (HUMA) and TSca...

Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), Humacyte (HUMA) and TScan Therapeutics (TCRX)

Analysts are intrested in these 5 stocks: ( ($ACHV) ), ( ($HUM) ), ( ($APTV) ), ( ($FIS) ) and ( ($ADM) ). Here is a breakdown of their recent


ACHV, HUM, APTV, FIS, ADM Trending With Analysts

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AMN Healthcare Services (AMN), Maravai Lifescience...

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Maravai Lifesciences Holdings (MRVI) and Humana (HUM)

An update from Hua Medicine ( ($HK:2552) ) is now available. Hua Medicine has warned shareholders that it expects to post a loss of about RMB30.2 m...

Hua Medicine Issues Profit Warning as One-Off Bayer Gain Drops Out

Analysts are intrested in these 5 stocks: ( ($PSA) ), ( ($HUM) ), ( ($QURE) ), ( ($SKHY) ) and ( ($FVRR) ). Here is a breakdown of their recent


Humana, Public Storage, uniQure, SK Hynix, Fiverr Trending

The latest announcement is out from Humacyte ( ($HUMA) ). On July 31, 2026, Humacyte disclosed that Nasdaq notified the company its common stock ha...

Humacyte Receives Nasdaq Notice on Bid Price Noncompliance

In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Hold rating on Humana, with a price target of $415.00. The company’s shar...

RBC Capital Sticks to Its Hold Rating for Humana (HUM)

Guggenheim analyst Jason Cassorla maintained a Buy rating on Humana yesterday and set a price target of $471.00. The company’s shares closed yester...

Guggenheim Keeps Their Buy Rating on Humana (HUM)

The latest announcement is out from Humana ( ($HUM) ). Humana reported second-quarter 2026 results on July 29, 2026, posting GAAP earnings per shar...

Humana Affirms 2026 Outlook Amid Strong Q2 Results

Humm Group Limited ( ($AU:HUM) ) has shared an update. Humm Group Limited has notified the market of the cessation of certain performance rights un...

Humm Group Adjusts Capital Structure as Performance Rights Lapse

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Humana (HUM) and Krystal Biotech (KRYS) with bullish...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Humana AB ( ($SE:HUM) ) has shared an update. Humana AB reported modest top-line growth for the second quarter of 2026, with net revenue up 3 perce...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HUM	$389.05	+1.06%	761.08K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HUM	$389.05	+1.1%	761.08K
3
4
5
6

HUM

Get Humana Inc. Data in Excel

Get Humana Inc. Data in Excel